ABSTRACT
The classification of diabetes mellitus in 2020 still starts with 2 major types, ie, type 1 and type 2, but each of these now includes a few uncommon variants. Understanding the many faces of the diabetes syndrome can make a difference in how clinicians select glucose-lowering therapy.
Footnotes
Dr. Hoogwerf has disclosed formerly being an employee of and currently owning stock in Eli Lilly and consulting for Mannkind Corp.
- Copyright © 2020 The Cleveland Clinic Foundation. All Rights Reserved.
- Byron J. Hoogwerf, MD, FACP, FACE⇑
- Emeritus, Department of Endocrinology, Diabetes, and Metabolism, Cleveland Clinic; Clinical Professor of Endocrinology, Medical Sciences Discipline, Central Michigan University College of Medicine, Mt. Pleasant
- Address: Byron J. Hoogwerf, MD, FACP, FACE, 8972 Huntington Pointe Drive, Sarasota, FL 34238; byronhoogwerf{at}gmail.com
ABSTRACT
The classification of diabetes mellitus in 2020 still starts with 2 major types, ie, type 1 and type 2, but each of these now includes a few uncommon variants. Understanding the many faces of the diabetes syndrome can make a difference in how clinicians select glucose-lowering therapy.
Footnotes
Dr. Hoogwerf has disclosed formerly being an employee of and currently owning stock in Eli Lilly and consulting for Mannkind Corp.
- Copyright © 2020 The Cleveland Clinic Foundation. All Rights Reserved.
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.